Sunil Healthcare

₹70.19As of Sun 8 Nov 2026, 12:00 UTC

NSE:SUNLOC—

Country India

PE (Fwd) 17.69

TSR 10Y CAGR —

Div yield —

ROE —

Miscellaneous Chemical Products

Beta (5Y) (0.06)

PE TTM 17.97

TSR TTM —

Mkt cap ₹691.1M

ROIC —

SE Grade™

—

Value

—

Quality

Moat

—

1Y Price

Reference

₹77

—

9.23%

—

FY23

FY24

FY25

FY26

Earnings per share₹

6.52

(1.74)

(1.38)

3.91

4.07%

(126.77%)

20.79%

382.79%

Revenue₹B

1.105

0.902

0.834

0.877

(7.28%)

(18.37%)

(7.51%)

5.15%

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

0.877

Revenue₹B

—

1.192

1.105

0.902

0.834

0.877

0.876

(7.37%)

5.15

Revenue growth%

—

(7.28)

(18.37)

(7.51)

5.15

(0.09)

(7.39)

—

61.03

Gross margin%

—

56.17

54.60

48.57

56.04

61.03

60.98

56.04

7.21

Operating margin%

—

9.65

8.30

(2.22)

4.68

7.21

7.17

7.21

4.57

Net margin%

—

5.39

6.05

(1.98)

(1.70)

4.57

4.59

4.57

17.97

P/E ratio (avg)x

—

17.90

—

11.38

EV/EBITx

—

11.46

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

3.91

EPS₹

—

6.26

6.52

(1.74)

(1.38)

3.91

3.92

(11.12%)

—

382.79

EPS growth%

—

4.07

(126.77)

20.79

382.79

0.36

12.43

—

100

—

Bookvalue per sh₹

—

FCF per share₹

—

Dividend per sh₹

—

Div yield (avg)%

—

Payout ratio%

—

10.25

Shares (diluted)M

—

10.25

◌10.25

—

Buyback yield%

—

◌—

—

D/E ratiox

—

719.8

Enterprise value₹M

—

719.8

—

LT debt₹M

—

Peers (US$7.387M)

Cap (US$)

Biopol Chemicals…

5.408M

4.033x

Saboo Sodium Chloro…

5.372M

35.12x

Vikram Aroma Limited

3.595M

—

Polychem Limited

7.430M

5.004x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

1.308

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

68.39

1.54

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

3/5

Revenue growth years

1/4

EPS growth years

3/4

Dividend streakyrs

Op margin range%

−2–10

$1 testx

—

Incr. ROIC%

—

Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. It offers EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, gelatin, HPMC/vegetable, and pullulan capsules.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹877.2M

(7.37%)

1.00×

Cost of revenue

₹341.8M

(10.06%)

0.89×

Operating expenses

₹472.1M

(3.93%)

1.16×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m